Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights

Raw and starting materials: troubleshooting supply, management and optimization issues

GUEST EDITOR: Dr Steven Goodman, Senior Director, Drug Product Manufacturing, bluebird bio
  • Starting material variability and its impact on reproducibility – managing regulatory and commercial repercussions
  • Weighing up emerging allogeneic cell sources: pros and cons in practice
    • iPSCs
    • Cord blood and tissue
  • Delivering apheresis/leukapheresis best practices
  • Securing supply of critical raw materials through scale-up
  • Ensuring maximum quality at minimal cost
Twitter IconVisit Our Blog